波立维联合拜阿司匹林治疗不稳定型心绞痛临床研究

目的 探讨波立维联合拜阿司匹林治疗不稳定型心绞痛(UPA)的疗效和安全性.方法 将UPA患者随机分为治疗组75例和对照组73例,治疗组用波立维75 mg,1日1次,共7天,拜阿司匹林100 mg,1日1次,共7天;对照组用安慰剂,1日1次,连续7天,拜阿司匹林100 mg,1日1次,共7天.结果 治疗组总有效率为94.7％,对照组为79.4％,两组疗效差异有显著性(P＜0.05).结论 治疗组较对照组起效快,作用强,效果好,安全性高.

Clinical research on clopidogrel combined with aspirin in unstable angina pectoris treatment

Objective To investigate the efficacy and safety of using Clopidogrel combined with aspirin in treatment for unstable angina pectoris （UAP）. Methods The UAP patients were randomly divided into two groups： the treatment group （ n = 75 ） and the control group （ n = 73）. The patients in the treatment group took 75 mg Clopidogrel and 100 nag aspirin once a day for a week. The patients in the control group took Placebot once a day for a week.Results Curative effects of the treatment group was obviously better than that of the control group with the cure rate 94.7% vs 79,4%, which was really statistically meaningful （P〈 0.05）. Conclusion The treatment in the first group has a quicker, stronger and better effect and is reliably safe.